tiprankstipranks
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market
Want to see CH:BSLN full AI Analyst Report?

Basilea Pharmaceutica (BSLN) Technical Analysis

7 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Basilea Pharmaceutica’s (BSLN) Moving Averages Convergence Divergence (MACD) indicator is 0.63, suggesting Basilea Pharmaceutica is a Sell.
Basilea Pharmaceutica’s (BSLN) 20-Day exponential moving average is 54.00, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Buy.
Basilea Pharmaceutica’s (BSLN) 50-Day exponential moving average is 53.67, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Buy.

Basilea Pharmaceutica (BSLN) Pivot Points

Apr 17, 2026, 02:50 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
52.73
53.67
54.83
55.77
56.93
57.87
59.03
Fibonacci
53.67
54.47
54.96
55.77
56.57
57.06
57.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Basilea Pharmaceutica (BSLN) Moving Averages

Apr 17, 2026, 02:50 AM
Period
Simple
Exponential
MA5
55.26Buy
55.51Buy
MA10
54.68Buy
54.71Buy
MA20
53.19Buy
54.00Buy
MA50
54.15Buy
53.67Buy
MA100
53.35Buy
52.90Buy
MA200
51.12Buy
50.97Buy
Basilea Pharmaceutica’s (BSLN) 10-Day exponential moving average is 54.71, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Buy.
Basilea Pharmaceutica’s (BSLN) 100-Day exponential moving average is 52.90, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Buy.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 50-day simple moving average is 54.15, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 100-day simple moving average is 53.35, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 200-day simple moving average is 51.12, creating a Buy signal.

Basilea Pharmaceutica (BSLN) Technical Indicators

Apr 17, 2026, 02:50 AM
Name
Value
Implied Action
RSI (14)
65.51
Neutral
STOCH (9,6)
79.31
Neutral
STOCHRSI (14)
83.83
Sell
MACD (12,26)
0.63
Sell
ADX (14)
15.32
Buy
Williams %R
-15.38
Sell
CCI (14)
161.03
Sell
ATR (14)
1.58
-
Ultimate Oscillator
45.82
Neutral
ROC
10.94
Buy
Basilea Pharmaceutica’s (BSLN) Relative Strength Index (RSI) is 65.51, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Trend Strength Indicator (ADX) is 15.32, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) Commodity Channel Index (CCI) is 161.03, creating a Sell signal.
Basilea Pharmaceutica’s (BSLN) Price Rate of Change (ROC) is 10.94, creating a Buy signal.

FAQ

Is BSLN a Buy, Hold, or Sell?
Based on BSLN’s technical indicators, BSLN is a Buy.
    What is BSLN’s RSI (14)?
    BSLN’s RSI (14) is 65.51, which suggests BSLN is a Neutral.
      What is BSLN’s MACD?
      BSLN’s MACD is 0.63, which suggests BSLN is a Sell.
        What is BSLN’s 5-day moving average?
        BSLN’s 5-day moving average is 55.26, which suggests BSLN is a Buy.
          What is BSLN’s 20-day moving average?
          BSLN 20-day moving average is 53.19, which suggests BSLN is a Buy.
            What is BSLN’s 50-day moving average?
            BSLN’s 50-day moving average is 54.15, which suggests BSLN is a Buy.
              What is BSLN’s 200-day moving average?
              BSLN’s 200-day moving average is 51.12, which suggests BSLN is a Buy.
                What is BSLN’s Williams % R (14)?
                BSLN’s Williams % R (14) is -15.38, which suggests BSLN is a Sell.
                  What is BSLN’s CCI (14)?
                  BSLN’s CCI (14) is 161.03, which suggests BSLN is a Sell.
                    What is the share price of Basilea Pharmaceutica?